BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 16938803)

  • 21. Linkage of a candidate gene locus to familial combined hyperlipidemia: lecithin:cholesterol acyltransferase on 16q.
    Aouizerat BE; Allayee H; Cantor RM; Dallinga-Thie GM; Lanning CD; de Bruin TW; Lusis AJ; Rotter JI
    Arterioscler Thromb Vasc Biol; 1999 Nov; 19(11):2730-6. PubMed ID: 10559018
    [TBL] [Abstract][Full Text] [Related]  

  • 22. USF1 and dyslipidemias: converging evidence for a functional intronic variant.
    Naukkarinen J; Gentile M; Soro-Paavonen A; Saarela J; Koistinen HA; Pajukanta P; Taskinen MR; Peltonen L
    Hum Mol Genet; 2005 Sep; 14(17):2595-605. PubMed ID: 16076849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of TNFRSF1B as a novel modifier gene in familial combined hyperlipidemia.
    Geurts JM; Janssen RG; van Greevenbroek MM; van der Kallen CJ; Cantor RM; Bu X; Aouizerat BE; Allayee H; Rotter JI; de Bruin TW
    Hum Mol Genet; 2000 Sep; 9(14):2067-74. PubMed ID: 10958645
    [TBL] [Abstract][Full Text] [Related]  

  • 24. No evidence of linkage between familial combined hyperlipidemia and genes encoding lipolytic enzymes in Finnish families.
    Pajukanta P; Porkka KV; Antikainen M; Taskinen MR; Perola M; Murtomäki-Repo S; Ehnholm S; Nuotio I; Suurinkeroinen L; Lahdenkari AT; Syvänen AC; Viikari JS; Ehnholm C; Peltonen L
    Arterioscler Thromb Vasc Biol; 1997 May; 17(5):841-50. PubMed ID: 9157946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Fifty years studying hiperlipidemias: the case of familial combined hyperlipidemia].
    Aguilar-Salinas C; Gómez-Díaz R; Tusié-Luna MT
    Invest Clin; 2010 Jun; 51(2):145-58. PubMed ID: 20928976
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genomewide scan for familial combined hyperlipidemia genes in finnish families, suggesting multiple susceptibility loci influencing triglyceride, cholesterol, and apolipoprotein B levels.
    Pajukanta P; Terwilliger JD; Perola M; Hiekkalinna T; Nuotio I; Ellonen P; Parkkonen M; Hartiala J; Ylitalo K; Pihlajamäki J; Porkka K; Laakso M; Viikari J; Ehnholm C; Taskinen MR; Peltonen L
    Am J Hum Genet; 1999 May; 64(5):1453-63. PubMed ID: 10205279
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Replication of linkage of familial combined hyperlipidemia to chromosome 1q with additional heterogeneous effect of apolipoprotein A-I/C-III/A-IV locus. The NHLBI Family Heart Study.
    Coon H; Myers RH; Borecki IB; Arnett DK; Hunt SC; Province MA; Djousse L; Leppert MF
    Arterioscler Thromb Vasc Biol; 2000 Oct; 20(10):2275-80. PubMed ID: 11031215
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic variants in adipose triglyceride lipase influence lipid levels in familial combined hyperlipidemia.
    Nanni L; Quagliarini F; Megiorni F; Montali A; Minicocci I; Campagna F; Pizzuti A; Arca M
    Atherosclerosis; 2010 Nov; 213(1):206-11. PubMed ID: 20832801
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Confirmed locus on chromosome 11p and candidate loci on 6q and 8p for the triglyceride and cholesterol traits of combined hyperlipidemia.
    Naoumova RP; Bonney SA; Eichenbaum-Voline S; Patel HN; Jones B; Jones EL; Amey J; Colilla S; Neuwirth CK; Allotey R; Seed M; Betteridge DJ; Galton DJ; Cox NJ; Bell GI; Scott J; Shoulders CC
    Arterioscler Thromb Vasc Biol; 2003 Nov; 23(11):2070-7. PubMed ID: 14500288
    [TBL] [Abstract][Full Text] [Related]  

  • 30. USF1 contributes to high serum lipid levels in Dutch FCHL families and U.S. whites with coronary artery disease.
    Lee JC; Weissglas-Volkov D; Kyttälä M; Sinsheimer JS; Jokiaho A; de Bruin TW; Lusis AJ; Brennan ML; van Greevenbroek MM; van der Kallen CJ; Hazen SL; Pajukanta P
    Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2222-7. PubMed ID: 17673701
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The lipoprotein lipase (Asn291-->Ser) mutation is associated with elevated lipid levels in families with familial combined hyperlipidaemia.
    Hoffer MJ; Bredie SJ; Boomsma DI; Reymer PW; Kastelein JJ; de Knijff P; Demacker PN; Stalenhoef AF; Havekes LM; Frants RR
    Atherosclerosis; 1996 Jan; 119(2):159-67. PubMed ID: 8808493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Common genetic variants contribute to primary hypertriglyceridemia without differences between familial combined hyperlipidemia and isolated hypertriglyceridemia.
    De Castro-Orós I; Cenarro A; Tejedor MT; Baila-Rueda L; Mateo-Gallego R; Lamiquiz-Moneo I; Pocoví M; Civeira F
    Circ Cardiovasc Genet; 2014 Dec; 7(6):814-21. PubMed ID: 25176936
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mapping a gene for combined hyperlipidaemia in a mutant mouse strain.
    Castellani LW; Weinreb A; Bodnar J; Goto AM; Doolittle M; Mehrabian M; Demant P; Lusis AJ
    Nat Genet; 1998 Apr; 18(4):374-7. PubMed ID: 9537422
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel variant in LPL gene is associated with familial combined hyperlipidemia.
    Taghizadeh E; Ghayour-Mobarhan M; Ferns GA; Pasdar A
    Biofactors; 2020 Jan; 46(1):94-99. PubMed ID: 31599081
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genotype at a major locus with large effects on apolipoprotein B levels predicts familial combined hyperlipidemia.
    Jarvik GP; Beaty TH; Gallagher PR; Coates PM; Cortner JA
    Genet Epidemiol; 1993; 10(4):257-70. PubMed ID: 8224806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Parabolic relationship between plasma triacylglycerols and LDL-cholesterol in familial combined hyperlipidaemia: the multiple-type hyperlipidaemia explained?
    Brouwers MC; de Graaf J; van Greevenbroek MM; Georgieva AM; van der Kallen CJ; Ter Avest E; Stehouwer CD; Stalenhoef AF; de Bruin TW
    Clin Sci (Lond); 2008 Mar; 114(5):393-401. PubMed ID: 17953518
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Two novel apolipoprotein A-IV variants in individuals with familial combined hyperlipidemia and diminished levels of lipoprotein lipase activity.
    Deeb SS; Nevin DN; Iwasaki L; Brunzell JD
    Hum Mutat; 1996; 8(4):319-25. PubMed ID: 8956036
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Familial-combined hyperlipidaemia in very young myocardial infarction survivors (< or =40 years of age).
    Wiesbauer F; Blessberger H; Azar D; Goliasch G; Wagner O; Gerhold L; Huber K; Widhalm K; Abdolvahab F; Sodeck G; Maurer G; Schillinger M
    Eur Heart J; 2009 May; 30(9):1073-9. PubMed ID: 19276196
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Haplotypes of the ApoA-I/C-III/A-IV gene cluster and familial combined hyperlipidemia.
    Tahvanainen E; Pajukanta P; Porkka K; Nieminen S; Ikävalko L; Nuotio I; Taskinen MR; Peltonen L; Ehnholm C
    Arterioscler Thromb Vasc Biol; 1998 Nov; 18(11):1810-7. PubMed ID: 9812922
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The V73M mutation in the hepatic lipase gene is associated with elevated cholesterol levels in four Dutch pedigrees with familial combined hyperlipidemia.
    Hoffer MJ; Snieder H; Bredie SJ; Demacker PN; Kastelein JJ; Frants RR; Stalenhoef AF
    Atherosclerosis; 2000 Aug; 151(2):443-50. PubMed ID: 10924721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.